tnMainLogo.jpg
 

Streamline Your Antibody Discovery Workflow [App Note]


IntellicytAppNote-FebArticle3

IntelliCyt_logo

Monoclonal antibodies are one of the fastest-growing classes of biopharmaceuticals and are the backbone of many treatment modalities.

Many antibodies engage the same target or target multiple members of a single signaling pathway, therefore drug developers are pushing to produce next generation antibody drugs against new targets with improved mechanisms of action, pharmacokinetics and delivery systems. The Intellicyt® iQue Screener platform provides an integrated solution that produces rapidly actionable results.

Download this application note to discover how you can:

  • Deliver rich content with lower sampling times
  • Reduce assay volumes and save cell and reagent costs
  • Dramatically reduce time and effort to generate useful results